Medical-device tax should be repealed, AdvaMed CEO says

06/10/2013 | Hill, The

The industry is seeing job cuts, capital-improvement delays and reduced R&D funding as a result of the medical-device tax that took effect Jan. 1, writes AdvaMed President and CEO Stephen Ubl. "We urge all healthcare stakeholders to join with the medical technology industry in fighting for repeal of this anti-patient, anti-job, anti-innovation tax. That is the best way to ensure no one has to absorb the tax's negative impact," he writes.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD